ArticleOncoTargets and therapy2017

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.

Zhan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.